Historical Valuation
Tenon Medical Inc (TNON) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1.76 is considered Overvalued compared with the five-year average of -3.02. The fair price of Tenon Medical Inc (TNON) is between 0.56 to 0.91 according to relative valuation methord. Compared to the current price of 0.97 USD , Tenon Medical Inc is Overvalued By 6.45%.
Relative Value
Fair Zone
0.56-0.91
Current Price：0.97
6.45%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Tenon Medical Inc (TNON) has a current Price-to-Book (P/B) ratio of 4.86. Compared to its 3-year average P/B ratio of 3.49 , the current P/B ratio is approximately 39.47% higher. Relative to its 5-year average P/B ratio of 3.03, the current P/B ratio is about 60.71% higher. Tenon Medical Inc (TNON) has a Forward Free Cash Flow (FCF) yield of approximately -111.78%. Compared to its 3-year average FCF yield of -253.71%, the current FCF yield is approximately -55.94% lower. Relative to its 5-year average FCF yield of -212.10% , the current FCF yield is about -47.30% lower.
P/B
Median3y
3.49
Median5y
3.03
FCF Yield
Median3y
-253.71
Median5y
-212.10
Competitors Valuation Multiple
AI Analysis for TNON
The average P/S ratio for TNON competitors is 0.48, providing a benchmark for relative valuation. Tenon Medical Inc Corp (TNON.O) exhibits a P/S ratio of 1.76, which is 268.43% above the industry average. Given its robust revenue growth of 32.24%, this premium appears sustainable.
Performance Decomposition
AI Analysis for TNON
1Y
3Y
5Y
Market capitalization of TNON increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of TNON in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is TNON currently overvalued or undervalued?
Tenon Medical Inc (TNON) is now in the Overvalued zone, suggesting that its current forward PS ratio of 1.76 is considered Overvalued compared with the five-year average of -3.02. The fair price of Tenon Medical Inc (TNON) is between 0.56 to 0.91 according to relative valuation methord. Compared to the current price of 0.97 USD , Tenon Medical Inc is Overvalued By 6.45% .
What is Tenon Medical Inc (TNON) fair value?
TNON's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Tenon Medical Inc (TNON) is between 0.56 to 0.91 according to relative valuation methord.
How does TNON's valuation metrics compare to the industry average?
The average P/S ratio for TNON's competitors is 0.48, providing a benchmark for relative valuation. Tenon Medical Inc Corp (TNON) exhibits a P/S ratio of 1.76, which is 268.43% above the industry average. Given its robust revenue growth of 32.24%, this premium appears sustainable.
What is the current P/B ratio for Tenon Medical Inc (TNON) as of Jan 10 2026?
As of Jan 10 2026, Tenon Medical Inc (TNON) has a P/B ratio of 4.86. This indicates that the market values TNON at 4.86 times its book value.
What is the current FCF Yield for Tenon Medical Inc (TNON) as of Jan 10 2026?
As of Jan 10 2026, Tenon Medical Inc (TNON) has a FCF Yield of -111.78%. This means that for every dollar of Tenon Medical Inc’s market capitalization, the company generates -111.78 cents in free cash flow.
What is the current Forward P/E ratio for Tenon Medical Inc (TNON) as of Jan 10 2026?
As of Jan 10 2026, Tenon Medical Inc (TNON) has a Forward P/E ratio of -0.85. This means the market is willing to pay $-0.85 for every dollar of Tenon Medical Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Tenon Medical Inc (TNON) as of Jan 10 2026?
As of Jan 10 2026, Tenon Medical Inc (TNON) has a Forward P/S ratio of 1.76. This means the market is valuing TNON at $1.76 for every dollar of expected revenue over the next 12 months.